Amyris price target lowered to $2 from $2.50 at Piper Sandler

Piper Sandler analyst Korinne Wolfmeyer lowered the firm’s price target on Amyris to $2 from $2.50 and keeps a Neutral rating on the shares. The analyst views view China, travel retail, and trade down as key themes to watch in 2023 for the beauty and wellness sector.